Zhang, Liping; Mann, Matthew; Zulfeqhar, Syed; Reynolds, Hayley; Tian, E; Samara, Nadine; Zeldin, Darryl; Tabak, Lawrence (23. november 2021). «Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation». Proceedings of the National Academy of Science of the United States of America. 118 (47): e2109905118. PMID34732583. doi:10.1073/pnas.2109905118.
Zhang, Liping; Mann, Matthew; Zulfeqhar, Syed; Reynolds, Hayley; Tian, E; Samara, Nadine; Zeldin, Darryl; Tabak, Lawrence (23. november 2021). «Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation». Proceedings of the National Academy of Science of the United States of America. 118 (47): e2109905118. PMID34732583. doi:10.1073/pnas.2109905118.
Tracking SARS-CoV-2 variants (Tables: Currently designated Variants Under Monitoring -describes 529 variant as present in 'Multiple countries'- and 'Formerly monitored variants'- B.1.523 & B.1.619 Reclassified Nov 2021). www.who.int, lest 25. november 2021
WHO. «EG.5 Initial Risk Evaluation, 9 August 2023»(PDF). Besøkt 18. august 2023. «While EG.5 has shown increased prevalence, growth advantage, and immune escape properties, there
have been no reported changes in disease severity to date. While concurrent increases in the proportion of EG.5
and COVID-19 hospitalizations (lower than previous waves) have been observed in countries such as Japan and
the Republic of Korea, no associations have been made between these hospitalizations and EG.5. However, due
to its growth advantage and immune escape characteristics, EG.5 may cause a rise in case incidence and become
dominant in some countries or even globally»linjeskift-tegn i |sitat= på plass 97 (hjelp)
